Your prediction
Pros and Cons of Panbela Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
Show more
Ratings data for PBLA provided by MarketBeat
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its price target lowered by analysts at Roth Mkm from $500.00 to $25.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBLA provided by MarketBeat
Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
Show more
Ratings data for PBLA provided by MarketBeat

